Bio-Connect
IHC-P analysis of human bladder carcinoma tissue using GTX34814 MAML2 antibody [MAML2/1302].
IHC-P analysis of human bladder carcinoma tissue using GTX34814 MAML2 antibody [MAML2/1302].
IHC-P analysis of human bladder carcinoma tissue using GTX34814 MAML2 antibody [MAML2/1302].

MAML2 antibody [MAML2/1302]

GTX34814
GeneTex
ApplicationsFlow Cytometry, ImmunoFluorescence, Western Blot, ImmunoCytoChemistry, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
Product group Antibodies
TargetMAML2
Sign in to order and to see your custom pricing.
Large volume orders?
Order with a bulk request

Overview

  • Supplier
    GeneTex
  • Product Name
    MAML2 antibody [MAML2/1302]
  • Delivery Days Customer
    9
  • Application Supplier Note
    WB: 1-2microg/ml. ICC/IF: 1-2microg/ml. IHC-P: 1-2microg/ml for 30 minutes at RT. FACS: 1-2microg/106 cells. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
  • Applications
    Flow Cytometry, ImmunoFluorescence, Western Blot, ImmunoCytoChemistry, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
  • Certification
    Research Use Only
  • Clonality
    Monoclonal
  • Clone ID
    MAML2/1302
  • Concentration
    0.2 mg/ml
  • Conjugate
    Unconjugated
  • Gene ID84441
  • Target name
    MAML2
  • Target description
    mastermind like transcriptional coactivator 2
  • Target synonyms
    MAM-3, MAM2, MAM3, MLL-MAML2, mastermind-like protein 2, mam-2, mastermind-like 2
  • Host
    Mouse
  • Isotype
    IgG2a
  • Protein IDQ8IZL2
  • Protein Name
    Mastermind-like protein 2
  • Scientific Description
    The protein encoded by this gene is a member of the Mastermind-like family of proteins. All family members are proline and glutamine-rich, and contain a conserved basic domain that binds the ankyrin repeat domain of the intracellular domain of the Notch receptors (ICN1-4) in their N-terminus, and a transcriptional activation domain in their C-terminus. This protein binds to an extended groove that is formed by the interaction of CBF1, Suppressor of Hairless, LAG-1 (CSL) with ICN, and positively regulates Notch signaling. High levels of expression of this gene have been observed in several B cell-derived lymphomas. Translocations resulting in fusion proteins with both CRTC1 and CRTC3 have been implicated in the development of mucoepidermoid carcinomas, while a translocation event with CXCR4 has been linked with chronic lymphocytic leukemia (CLL). Copy number variation in the polyglutamine tract has been observed. [provided by RefSeq, Jan 2015]
  • Storage Instruction
    -20°C or -80°C,2°C to 8°C
  • UNSPSC
    12352203